This page shows the latest HIV news and features for those working in and with pharma, biotech and healthcare.
Previously, protease inhibitors have been effective for the treatment of other viral pathogens, including HIV and hepatitis C virus, when administered alone and in combination with additional antivirals.
outcomes and lives in HIV and cancer.
adults, while a second cohort evaluated the vaccine in around 240 medically stable, HIV-positive volunteers. ... Among HIV-negative participants, the efficacy of NVX-CoV2373 was found to be 55.4%, with complete analysis showing that vaccine-induced
It also holds the promise of applying lessons learned to help develop potentially curative options for other debilitating diseases affecting low-income populations, such as HIV,” he added.
its other investigational candidates for Zika, RSV and HIV.
business. This included HIV products sales, which were down 7% in the fourth quarter to $4.3bn – although full-year sales were up 3% to $16.9bn in 2020.
More from news
Approximately 91 fully matching, plus 547 partially matching documents found.
This was big news, a landmark moment for the HIV community: undetectable = untransmittable. ... Helping prevent further HIV transmission and protect those living with HIV to live longer, healthier lives.
A combination HIV treatment: AbbVie’s Kaletra. In an unprecedented move, AbbVie has suspended its patents on its combination HIV drug Kaletra, after it was identified as having potential against ... 19. Kaletra combines two antivirals, lopinavir and
We already have effective mechanisms that fund access to vaccines, TB, HIV and malaria.
The strategy echoes its HIV heritage and continuing practice of working closely with patient groups in all aspects of drug development. ... He added: “We have medicines that provide good treatments for a broad group of patients, particularly those
The success of vaccines, antibiotics, HIV treatments and many other therapies is evidence of how society has benefited from the deal.
More from intelligence
Approximately 4 fully matching, plus 53 partially matching documents found.
Joseph also has expertise in a number of therapeutics areas, including cardiovascular, upper respiratory, HIV, dermatology and more.
In her new role at Porter Novelli, Tovey will work across a global pharmaceutical client portfolio that includes neurology, rare diseases and HIV.
its HIV vaccine. ... After decades of work to develop a HIV vaccine, I hope to contribute with my experience in building a strong player that I believe has good chances to be amongst the
Fay Lepley also joins the agency as an account executive and has had experience working in PR and healthcare communications across several therapy areas including cardiovascular, diabetes and HIV.
GlaxoSmithKline has promoted Deborah Waterhouse to replace ViiV Healthcare's CEO Dominique Limet when he steps down from the HIV-focused firm at the end of March. ... We have delivered scientific innovation, while listening and better understanding the
More from appointments
Approximately 1 fully matching, plus 15 partially matching documents found.
Thinking back to the HIV campaigns of the 1980s, which focused on fear to try to prevent the spread of HIV, they may have had short-term success in raising awareness ... a lot of outdated knowledge and opinion about HIV amongst the general population,
However, once these trials are divided up into specific diseases the underrepresentation becomes clearer, especially in the fields of cardiovascular diseases, hepatitis, HIV, chronic kidney disease and digestive diseases.
One perspective presented during this session was how the treatment of HIV has been ‘Globalised’ and what lessons can be learned from this.
She has led the launches of new HIV treatments in the EU, developing media strategies and approaches ahead of regulatory milestones and data announcements at multiple congresses.
More likely to be living with HIV. More likely to be homeless or insecurely housed. ... Undiagnosed HIV infection” and “Heart disease risk” - as well as talk around key evidence gaps, donor eligibility and lifestyle factors including diet, alcohol
More from PMHub
Approximately 4 fully matching, plus 32 partially matching documents found.
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...